ADC Therapeutics SA
Develops targeted antibody-drug conjugates for hematological and solid tumors.
ADCT | NYSE
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- BIOPOLE, 1066 EPALINGES
- Website:
- https://adctherapeutics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ADC Therapeutics SA is a commercial-stage, oncology-focused biotechnology company pioneering the development and commercialization of next-generation antibody-drug conjugates (ADCs). The company leverages its proprietary technology platform to create highly targeted therapies for patients with both hematological malignancies and solid tumors. Its ADCs are designed to combine the specificity of monoclonal antibodies with a potent cancer-killing payload, enabling the selective destruction of cancer cells. ADC Therapeutics is focused on advancing its clinical pipeline to transform the treatment paradigm for patients with difficult-to-treat cancers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ADC Therapeutics SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ADC Therapeutics SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ADC Therapeutics SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
